Phathom Pharmaceuticals Competitors and Similar CompaniesClear all
Phathom Pharmaceuticals's competitors and similar companies include Immatics.
 Phathom Pharmaceuticals Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Buffalo Grove, US HQ Florham Park, US Menlo Park, US | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US |
Employees | Employees 1633% increase | Employees 29723% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 1.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) $175.1m (FY, 2025) | Revenue (est.) €48.3m (FY, 2025) |
Cost of goods | Cost of goods $22.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $152.5m (FY, 2025) | Gross profit €53m (FY, 2025) |
Net income | Net income ($221.2m) (FY, 2025) | Net income (€196.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 140m | Total funding raised $ 267.3m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company